Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 9 studies | 32% ± 11% | |
| endothelial cell | 6 studies | 26% ± 7% | |
| glutamatergic neuron | 6 studies | 45% ± 25% | |
| epithelial cell | 6 studies | 32% ± 11% | |
| GABAergic neuron | 6 studies | 38% ± 21% | |
| oligodendrocyte precursor cell | 6 studies | 31% ± 12% | |
| microglial cell | 5 studies | 26% ± 7% | |
| astrocyte | 5 studies | 36% ± 13% | |
| macrophage | 5 studies | 22% ± 6% | |
| endothelial cell of lymphatic vessel | 4 studies | 17% ± 1% | |
| interneuron | 4 studies | 41% ± 23% | |
| adipocyte | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 9 studies | 36% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 1152.28 | 245 / 245 | 100% | 7.10 | 501 / 502 |
| breast | 100% | 1041.40 | 459 / 459 | 99% | 8.17 | 1111 / 1118 |
| lung | 100% | 848.54 | 577 / 578 | 99% | 7.64 | 1148 / 1155 |
| thymus | 100% | 1251.55 | 653 / 653 | 99% | 7.83 | 599 / 605 |
| esophagus | 100% | 789.64 | 1445 / 1445 | 99% | 7.93 | 181 / 183 |
| pancreas | 100% | 731.37 | 328 / 328 | 99% | 7.10 | 176 / 178 |
| bladder | 100% | 1183.48 | 21 / 21 | 99% | 6.91 | 498 / 504 |
| intestine | 100% | 1017.99 | 966 / 966 | 99% | 7.45 | 520 / 527 |
| ovary | 100% | 1541.69 | 180 / 180 | 99% | 6.44 | 424 / 430 |
| uterus | 100% | 1272.08 | 170 / 170 | 98% | 6.88 | 451 / 459 |
| stomach | 100% | 710.82 | 359 / 359 | 98% | 7.39 | 280 / 286 |
| brain | 100% | 909.83 | 2637 / 2642 | 98% | 5.20 | 691 / 705 |
| kidney | 100% | 925.42 | 89 / 89 | 96% | 6.11 | 869 / 901 |
| adrenal gland | 100% | 873.65 | 258 / 258 | 94% | 5.28 | 216 / 230 |
| skin | 100% | 1007.07 | 1808 / 1809 | 92% | 6.23 | 432 / 472 |
| liver | 100% | 560.54 | 226 / 226 | 78% | 3.77 | 316 / 406 |
| adipose | 100% | 965.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1351.70 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.59 | 1 / 1 |
| blood vessel | 100% | 805.70 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 97% | 363.46 | 777 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 1179.19 | 898 / 929 | 0% | 0 | 0 / 0 |
| heart | 96% | 417.58 | 825 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 5.72 | 43 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 86% | 4.24 | 25 / 29 |
| eye | 0% | 0 | 0 / 0 | 80% | 4.36 | 64 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051604 | Biological process | protein maturation |
| GO_0035269 | Biological process | protein O-linked mannosylation |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0004169 | Molecular function | dolichyl-phosphate-mannose-protein mannosyltransferase activity |
| Gene name | TMEM260 |
| Protein name | Protein O-mannosyl-transferase TMEM260 (EC 2.4.1.109) (Transmembrane protein 260) Transmembrane protein 260 |
| Synonyms | C14orf101 |
| Description | FUNCTION: O-mannosyl-transferase that transfers mannosyl residues to the hydroxyl group of serine or threonine residues of proteins . Specifically glycosylates the IPT/TIG domain of target proteins, such as MET and MST1R/RON . TMEM260-mediated O-mannosylated residues are composed of single mannose glycans that are not elongated or modified . . |
| Accessions | ENST00000539559.6 F5H7D0 ENST00000261556.11 [Q9NX78-1] ENST00000556810.5 ENST00000538838.5 [Q9NX78-3] H0YJK2 ENST00000556422.5 G3V4Y3 ENST00000555497.5 H0YJX9 ENST00000555905.5 G3V320 H0YK00 ENST00000556929.5 Q9NX78 ENST00000555046.1 G3V4A2 |